SCHEDULE OF WARRANTS ACTIVITY (Details) - $ / shares |
6 Months Ended | 12 Months Ended |
|---|---|---|
Jun. 30, 2026 |
Dec. 31, 2025 |
|
| Warrants | ||
| Warrants outstanding, Beginning balance | 1,800,000 | 1,650,000 |
| Weighted-Average Exercise Price, Warrants outstanding, Beginning balance | $ 2.85 | $ 1.10 |
| Warrants, Granted | 150,000 | 250,000 |
| Weighted-Average Exercise Price, Granted | $ 3.00 | $ 3.12 |
| Warrants, Canceled and expired | (100,000) | |
| Weighted-Average Exercise Price, Canceled and expired | $ 3.20 | |
| Warrants, Exercised | ||
| Weighted-Average Exercise Price, Exercised | ||
| Warrants outstanding, Ending balance | 1,950,000 | 1,800,000 |
| Weighted-Average Exercise Price, Warrants outstanding, Ending balance | $ 2.86 | $ 2.85 |
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non-options outstanding weighted average exercise price. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non-options outstanding weighted average exercise price cancelled. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non-options outstanding weighted average exercise price exercised. No definition available.
|
| X | ||||||||||
- Definition Share based compensation arrangement by share based payment award non-options outstanding weighted average exercise price granted. No definition available.
|
| X | ||||||||||
- Definition Number of non-option equity instruments exercised by participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of shares under non-option equity instrument agreements that were either cancelled or expired. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Net number of non-option equity instruments granted to participants. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Number of equity instruments other than options outstanding, including both vested and non-vested instruments. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|